Ownership Summary
Quarter ending 30 Jun, 2026
Molecular Partners Ag (NASDAQ:MOLN) has 5 institutional investors that have filed 13F reports for the period ending June 2026.
- These investors held 9.6% of outstanding shares in June 2026, up from 9.6% in March 2026.
- Their total shares held in MOLN increased 0.49% quarter over quarter, and separately, investors owning Molecular Partners Ag decreased 28.57% from a year ago.
- Of these 5 holders, 2 added to their stakes in Molecular Partners Ag, 0 trimmed positions, and 3 made no changes.
- Institutional investors collectively held 3.59Mn shares in Molecular Partners Ag as of June 2026, up by 17.46K shares quarter on quarter, and down 3.92K shares year over year.
- MONTANOVA CAPITAL, LLC is the top holder of Molecular Partners Ag as of June 30, 2026, with 2.22Mn shares representing 5.96% of outstanding stock.
- The most significant purchases of MOLN for the quarter ending June 2026 came from CITADEL ADVISORS LLC (17.18K), UBS Group AG (279).
- According to Business Quant data, leading holders of MOLN for June 2026 are MONTANOVA CAPITAL, LLC (2.22Mn), BVF INC/IL (1.35Mn), CITADEL ADVISORS LLC (17.18K), Morgan Stanley (367), UBS Group AG (279).